T NAKATANI

618 total citations
10 papers, 540 citations indexed

About

T NAKATANI is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, T NAKATANI has authored 10 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in T NAKATANI's work include Virus-based gene therapy research (3 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). T NAKATANI is often cited by papers focused on Virus-based gene therapy research (3 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). T NAKATANI collaborates with scholars based in Japan, United States and China. T NAKATANI's co-authors include Shigeki Kuriyama, Hiroshi Fukui, Hitoshi Yoshiji, Yasuhide Ikenaka, Hirohisa Tsujinoue, Ryuichi Noguchi, Junichi Yoshii, Masatoshi Kudo, Hye Soo Chung and M. Nagashima and has published in prestigious journals such as Hepatology, International Journal of Cancer and Alcoholism Clinical and Experimental Research.

In The Last Decade

T NAKATANI

10 papers receiving 525 citations

Peers

Countries citing papers authored by T NAKATANI

Since Specialization

Citations

This map shows the geographic impact of T NAKATANI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T NAKATANI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T NAKATANI more than expected).

Fields of papers citing papers by T NAKATANI

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T NAKATANI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T NAKATANI. The network helps show where T NAKATANI may publish in the future.

Co-authorship network of co-authors of T NAKATANI

This figure shows the co-authorship network connecting the top 25 collaborators of T NAKATANI. A scholar is included among the top collaborators of T NAKATANI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T NAKATANI. T NAKATANI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Regulatory failure of serum prohepcidin levels in patients with hepatitis C 2006 ·Hepatology Research ·M. Nagashima, Masatoshi Kudo, Hye Soo Chung, Eiji Ishikawa, Susumu Hagiwara, T NAKATANI, Kensaku Dote	57
2	Effects of fish oil feeding and fasting on LXRα/RXRα binding to LXRE in the SREBP-1c promoter in mouse liver 2005 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·T NAKATANI, (unknown), Shinji Miura, Yasutomi Kamei, Osamu Ezaki	21
3	Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats 2001 ·Hepatology ·Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Yasuhide Ikenaka, Ryuichi Noguchi, T NAKATANI, Hirohisa Tsujinoue, Hiroshi Fukui	334
4	Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats 2001 ·Hepatology ·Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Yasuhide Ikenaka, Ryuichi Noguchi, T NAKATANI, Hirohisa Tsujinoue, Hiroshi Fukui	22
5	Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice 1999 ·International Journal of Cancer ·Shigeki Kuriyama, Masaji Kikukawa, Kazuhiro Masui, (unknown), T NAKATANI, (unknown), Hitoshi Yoshiji, Hiroshi Fukui, (unknown), Craig A. Mullen, Tadasu Tsujii	35
6	Comparison of carcinoembryonic antigen promoter regions isolated from human colorectal carcinoma and normal adjacent mucosa to induce strong tumor-selective gene expression 1998 ·International Journal of Cancer ·Guangwen Cao, Shigeki Kuriyama, Jun Gao, Akira Mitoro, Long Cui, T NAKATANI, (unknown), Masaji Kikukawa, (unknown), Hiroshi Fukui, Zhongtian Qi	16
7	Role of Albumin and High‐Density Lipoprotein as Endotoxin‐Binding Proteins in Rats with Acute and Chronic Alcohol Loading 1996 ·Alcoholism Clinical and Experimental Research ·Hiroyuki Kitano, Hiroshi Fukui, Yasuyuki Okamoto, (unknown), Masami Matsumoto, Masaji Kikukawa, (unknown), (unknown), (unknown), T NAKATANI, Akira Takaya, Tadasu Tsujii	25
8	Effects of continuous intrahepatic administration of transforming growth factor-beta on immunoglobulin production 1995 ·International Hepatology Communications ·Masahiro Yoshikawa, Yoshio Matsui, (unknown), T NAKATANI, Junichi Yamao, Shinichi Kuriyama, Shinji Ishizaka, Hiroshi Fukui, Tadasu Tsujii	2
9	Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5-fluorocytosine 1995 ·International Hepatology Communications ·Shigeki Kuriyama, Kazuhiro Masui, Takemi Sakamoto, T NAKATANI, (unknown), Hiroshi Fukui, (unknown), Craig A. Mullen, Tadasu Tsujii	10
10	Gene therapy for the treatment of hepatoma by retroviral-mediated gene transfer of the herpes simplex virus thymidine kinase 1993 ·International Hepatology Communications ·Shigeki Kuriyama, Masahiro Yoshikawa, (unknown), T NAKATANI, (unknown), Hiroshi Fukui, (unknown), (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact